
SympTrack Health
AI supported patient monitoring that turns everyday health experiences into actionable insights for healthcare providers.
Atlanta, Georgia, United States
SympTrack Health is an AI-supported digital health platform that helps patients track symptoms between appointments and gives healthcare providers clearer, actionable insights to support care decisions.
SympTrack Health is an early-stage digital health startup developing a multi-specialty platform to improve communication between patients and healthcare providers. Our patient application, MyRelief, enables individuals to document symptoms, pain, fatigue, medications, and daily functioning between medical appointments. Our provider platform organizes this information into accessible patient histories and clinical summaries. Sophie, our AI assistant, helps transform patient-reported information into concise insights that support clinical review without replacing provider judgment. We currently have an interactive prototype demonstrating the patient and provider experiences. Our next milestones include developing a secure, HIPAA-ready production platform, conducting structured clinical validation beginning in rheumatology, and establishing healthcare partnerships. Our mission is to reduce gaps in communication, support more informed care decisions, and make the experiences patients have between appointments more visible to their care teams. Better understanding. Better tomorrows.
Company Info
- Website
- www.symptrackhealth.net/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of SympTrack Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.


Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment